Clinical trial
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756 · Johns Hopkins University, Other · Active, not recruiting
Key facts
| NCT number | NCT00431756 |
|---|---|
| Title | Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus |
| Official title | Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus (Previously: Methylation in Cancer Progression of Barrett's Esophagus |
| Acronym | BE |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH National Cancer Institute (NCI) |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Barrett Esophagus, Esophageal Neoplasm, Gastroesophageal Reflux |
| Enrollment | 600 |
| Start date | May 1, 2002 |
| Primary completion | May 1, 2023 |
| Completion | Jun 1, 2026 |
| First posted | Feb 6, 2007 |
| Last update posted | Dec 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: